Alpha Projects Competitors

Maker of Brite Lite Cycling Lighting Systems

* AlphaBeta is now hiring economists, consultants and policy experts. * AlphaBeta is a strategic economics consultancy that works with governments, businesses, investors, and other institutions to tackle the largest societal challenges we face. We believe that rigorous economics combined with strong strategic advice can help provide new, innovative and practical solutions to addressing issues ranging from automation of jobs, biodiversity loss to poverty alleviation. In short, at AlphaBeta, we strive to create economic models that will underpin a world that should exist, but doesn’t today. Our headquarters is in Singapore, but our work is global. We solve ‘top-of-mind’ issues related to growth, profitability, sustainability, and regulatory strategy. We take macroeconomic analysis from the 30,000-foot level and translate it into practical, actionable advice to help our clients create new jobs, develop sectors, combat climate change, and improve digital financial inclusion. Our clients include the Singapore government, multilateral institutions such as ASEAN, the United Nations and the World Economic Forum, and leading companies including Google and Netflix. On Nov 29, 2021, AlphaBeta joined Access Partnership, a leading global public policy firm, focused on digital sector, with offices around the world. Both organisations share the same mission in helping businesses and governments create positive societal change. Being a part of the globally recognised Access Partnership platform allows us to deepen our technology expertise, which is proving increasingly critical to our work also in sustainability and economic development, and grow our team across offices in the UK, Europe, the US, Africa, Latin America, and across Asia. See our job openings at www.alphabeta.com/careers

Zeta Corporation is an ISO 13485:2016 and FDA registered biomedical company that manufactures and distributes IVD antibodies for Pathology/IHC. We provide the highest quality of antibodies to help pathologists diagnose human tumors and diseases. Zeta antibodies are carefully curated to produce reproducible results on formalin-fixed, paraffin-embedded (FFPE) sections manually or using commercially available automated equipment. Zeta utilizes its collective knowledge of over 75 years to validate and standardize every antibody individually for immunohistochemistry (IHC) application. Zeta designs and develops tumor-specific biomarkers using cutting-edge technology to uniquely select the immunogens for our famed RAbMono™ (Rabbit Monoclonal) and MonoMAb™ (Monospecific monoclonal antibodies). Zeta’s MonoMAb™ and RAbMono™ Antibodies are produced through hybridoma and recombinant technologies. MonoMAb™: The clones are first screened by ELISA and gel electrophoresis to determine their specificity. The selected antibodies are further screened by staining FFPE sections. Only those antibodies that worked on FFPE sections are selected for further protein array analysis to select the highly specific clones for IHC. RAbMono™: Rabbit monoclonal primary antibodies are designed and developed by Zeta’s accomplished scientists and validated to perform with high sensitivity and specificity. It is our commitment to produce and release several primary antibodies for the routine and unique targets. We are proud of our commitment to producing highly specific, target-validated, and characterized IVD primary biomarkers to aid pathologists in the differential diagnosis of various tumors. Zeta Corporation sells the products directly in the US and distributes them to over 50 different countries globally through our trusted partners. Zeta offers CE-IVD labeled products with European regulatory compliance and encourages distributors to register the products in the individual territories.